【摘要】：目的觀察依達拉奉注射液聯合瓜蔞皮注射液治療急性缺血性腦卒中的臨床療效及安全性。方法將134例急性缺血性腦卒中患者隨機分為對照組67例和試驗組67例。對照組予以依達拉奉注射液30 mg,qd,靜脈滴注;試驗組在對照組治療的基礎上,予以瓜蔞皮注射液20 m L,qd,靜脈滴注。2組患者均治療12 d。比較2組患者的臨床療效、神經功能缺損(NIHSS)評分和生活自理能力(BI)評分、C反應蛋白(CRP)、白細胞介素-6(IL-6)和腫瘤壞死因子-α(TNF-α)的水平,以及藥物不良反應的發(fā)生情況。結果治療后,試驗組和對照組的總有效率分別為92.54%(62/67例)和76.12%(51/67例),差異有統計學意義(P0.05)。治療后,試驗組和對照組的NIHSS評分分別為(11.91±2.33)和(13.21±3.35)分,BI評估量表評分分別為(62.32±12.83)和(52.72±16.53)分,CRP分別為(3.92±1.15)和(7.12±1.96)mg·d L-1,IL-6分別為(15.54±4.93)和(19.23±3.84)ng·L-1,TNF-α分別為(26.85±8.75)和(43.73±12.52)ng·m L-1,差異均有統計學意義(均P0.05)。試驗期間,2組患者均未發(fā)生藥物不良反應。結論依達拉奉注射液聯合瓜蔞皮注射液治療急性缺血性腦卒中的臨床療效確切,其能明顯降低患者的神經功能缺損程度,改善血清炎癥因子水平,且安全性較高。
[Abstract]:Objective to observe the clinical efficacy and safety of Edaravone injection combined with Gualoupi injection in the treatment of acute ischemic stroke. Methods 134 patients with acute ischemic stroke were randomly divided into control group (67 cases) and experimental group (67 cases). The control group was treated with Edaravone injection 30 mg / g QD, and the experimental group was treated with Gualoupi injection 20 m / L QD on the basis of the control group, and all the patients in the control group were treated for 12 days by intravenous drip of Edaravone injection. The clinical efficacy, (NIHSS) score of neurological impairment and (BI) score of self-care ability were compared between the two groups. The levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor- 偽 (TNF- 偽), and the occurrence of adverse drug reactions were compared. Results after treatment, the total effective rates of the experimental group and the control group were 92.54% (62 / 67 cases) and 76.12% (51 / 67 cases), respectively. The difference was statistically significant (P0.05). After treatment, the NIHSS scores of the test group and the control group were (11.91 鹵2.33) and (13.21 鹵3.35) respectively (62.32 鹵12.83) and (52.72 鹵16.53), respectively. The scores of NIHSS were (3.92 鹵1.15) and (7.12 鹵1.96) mg d L ~ (-1) and (15.54 鹵4.93) and (19.23 鹵3.84) ng / L ~ (-1) ng m L ~ (-1), respectively (26.85 鹵8.75) and (43.73 鹵12.52) ng m L ~ (-1), respectively (P 0.05). There were no adverse drug reactions in both groups during the trial. Conclusion Edaravone injection combined with trichosanthes peel injection is effective in the treatment of acute ischemic stroke. Edaravone injection can obviously reduce the degree of neurological deficit and improve the level of serum inflammatory factors.
【作者單位】： �？谑腥嗣襻t(yī)院神經內科;海南省農墾總局醫(yī)院神經外科;
【基金】：海南省自然科學基金資助項目(814375)
【分類號】：R743.3

【參考文獻】

相關期刊論文 前1條

1 ;各類腦血管疾病診斷要點[J];中華神經科雜志;1996年06期

【共引文獻】

相關期刊論文 前10條

1 戚勝;董立煥;成杰;王云龍;劉萍萍;劉艷豐;王衛(wèi)亮;張愛麗;;腦卒中后急性應激障礙患者發(fā)生便秘的影響因素[J];中國健康心理學雜志;2017年09期

2 張銀善;張敏;趙志英;高昊;;微創(chuàng)血腫清除術后結合自擬活血化瘀醒腦湯治療高血壓腦出血療效觀察[J];現代中西醫(yī)結合雜志;2017年25期

3 陳敬敏;;活血化瘀法對高血壓腦出血患者血清GFAP、S100β蛋白、血紅素加氧酶1及非結合膽紅素影響研究[J];現代中西醫(yī)結合雜志;2017年25期

4 沈凌;;家庭醫(yī)生責任制延續(xù)性管理方式對社區(qū)老年腦卒中患者的影響[J];中華保健醫(yī)學雜志;2017年04期

5 李新杰;喬欽增;王靜;左慧;;健康教育照護者對腦卒中后抑郁患者療效的影響[J];預防醫(yī)學情報雜志;2017年08期

6 唐暉;;中西醫(yī)結合治療急性缺血性腦血管病42例臨床觀察[J];湖南中醫(yī)雜志;2017年08期

7 張麗敏;梁增坤;;醒腦靜聯合鹽酸納洛酮治療腦出血后昏迷55例療效觀察[J];湖南中醫(yī)雜志;2017年08期

8 李文豪;張巖;李響;張洪蕊;鄭向楠;;分期針刺治療周圍性面癱30例療效觀察[J];湖南中醫(yī)雜志;2017年08期

9 韓林;高e，

本文編號：2177300